Whether you're facing age-related hormone decline, recovering from injury, or seeking the edge in performance, HGH therapywhen used correctlyoffers profound, lasting benefits
Unlike full HGH, it does not raise IGF-1 levels significantly , so its unlikely to have the side effects associated with growth hormone therapy (like blood sugar swings or joint pain)
Ipamorelin: selective GHS-R1a agonist minimal cortisol, prolactin, or appetite effects GHRP-6: GHS-R1a agonist with additional CRH/ACTH activation, prolactin release, and potent orexigenic activity Ipamorelin selectivity ratio (GH:cortisol) is among the highest of all synthetic GHRPs GHRP-6 was instrumental in GHS-R1a receptor identification but is pharmacologically non-selective GH Release Profiles & Pulse Amplitude Both ipamorelin and GHRP-6 stimulate pulsatile GH release from anterior pituitary somatotrophs via GHS-R1a activation, working synergistically with endogenous GHRH
Always review complete prescribing information and discuss potential risks with your healthcare provider before starting any treatment
